Metraipolis › archive › dc_eb2c03ba6be8
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in… — Europe PMC PMID:42342968
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42342968
- DOI
- 10.1038/s41409-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T04:54:29.299Z
- SHA-256 of the archived text
ee39369b37b59cc3ecfe10bbb05fb9f9c4939185f8a8ab6ae4b91106ab724bf3- Stable URL of this page
https://metraipolis.com/documento/dc_eb2c03ba6be8
How to cite
A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in… — Europe PMC PMID:42342968 — Europe PMC (en), https://europepmc.org/article/MED/42342968 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb2c03ba6be8 (Metraipolis archive dc_eb2c03ba6be8, sha256 ee39369b37b59cc3ecfe10bbb05fb9f9c4939185f8a8ab6ae4b91106ab724bf3)
BibTeX
@misc{dceb2c03ba6be8,
title = {A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in… — Europe PMC PMID:42342968},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42342968},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb2c03ba6be8; sha256 ee39369b37b59cc3ecfe10bbb05fb9f9c4939185f8a8ab6ae4b91106ab724bf3},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42342968. Agents can read the archived copy with the MCP tool read_document.